Physician profile
Michael J Maynard
NPI 1861467649
$2,860.36
in general payments reported to CMS, 2019-2025
8 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.69 · 2020: $121 · 2021: $41.41 · 2022: $1,589 · 2023: $697 · 2024: $125 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634 · Travel and Lodging: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.20 |
| Travel and Lodging | $424.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,209.31 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $183.15 | 2025 | Juggerknotless Soft Anchor |
| Stryker Corporation | $144.13 | 2020-2021 | |
| Kerecis Limited | $125.05 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Orthalign INC | $101.00 | 2023 | Orthalign Plus |
| Smith+Nephew, INC. | $50.69 | 2019 | |
| Coastal Medical Technologies LLC | $29.17 | 2025 | |
| Djo, LLC | $17.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maynard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.